Case Report| Volume 44, ISSUE 5, P353-356, May 2022

Download started.


Successful treatment with dimethyl fumarate in a child with relapsing-remitting multiple sclerosis



      Early disease control with disease-modifying drugs is important for improving the prognosis of multiple sclerosis (MS) in children. Dimethyl fumarate (DMF) is an oral disease-modifying drug for MS in adults with relatively stable disease; however, its use in young children has not been heavily documented in the current literature. We report the case of a pediatric patient with relapsing-remitting MS who was treated with DMF.

      Case report

      A 3-year-old boy with a history of common cold symptoms developed unsteadiness and somnolence. Magnetic resonance imaging revealed multiple white matter lesions. Symptoms were recurrent, and DMF was prescribed at 6 years of age due to a relapse episode with oculomotor disability and facial paralysis. However, disease progression continued, and new lesions were noted at age 7; thus, the dose of DMF was increased to 240 mg/day. No relapse has been observed for over three years; sequelae or severe side effects were absent.


      DMF may be a useful oral disease-modifying drug for preventing recurrence in young children with MS.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Grigoriadis N.
        • van Pesch V.
        ParadigMS Group. A basic overview of multiple sclerosis immunopathology.
        Eur J Neurol. 2015; 22: 3-13
        • Gorman M.P.
        • Healy B.C.
        • Polgar-Turcsanyi M.
        • Chitnis T.
        Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis.
        Arch Neurol. 2009; 66: 54-59
        • Langille M.M.
        • Rutatangwa A.
        • Francisco C.
        Pediatric multiple sclerosis: a review.
        Adv Pediatr. 2019; 66: 209-229
        • Amato M.P.
        • Krupp L.B.
        • Charvet L.E.
        • Penner I.
        • Till C.
        Pediatric multiple sclerosis: Cognition and mood.
        Neurology. 2016; 87: S82-S87
        • Dobson R.
        • Giovannoni G.
        Multiple sclerosis – a review.
        Eur J Neurol. 2019; 26: 27-40
        • Polman C.H.
        • Reingold S.C.
        • Banwell B.
        • Clanet M.
        • Cohen J.A.
        • Filippi M.
        • et al.
        Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria.
        Ann Neurol. 2011; 69: 292-302
        • Sadaka Y.
        • Verhey L.H.
        • Shroff M.M.
        • Branson H.M.
        • Arnold D.L.
        • Narayanan S.
        • et al.
        2010 McDonald criteria for diagnosing pediatric multiple sclerosis.
        Ann Neurol. 2012; 72: 211-223
        • Faissner S.
        • Gold R.
        Oral therapies for multiple sclerosis.
        Cold Spring Harb Perspect Med. 2019; 9a032011
        • Chitnis T.
        • Arnold D.L.
        • Banwell B.
        • Brück W.
        • Ghezzi A.
        • Giovannoni G.
        • et al.
        Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.
        N Engl J Med. 2018; 379: 1017-1027
        • Deeks E.D.
        Dimethyl fumarate: a review in relapsing-remitting MS.
        Drugs. 2016; 76: 243-254
        • Alroughani R.
        • Huppke P.
        • Mazurkiewicz-Beldzinska M.
        • Blaschek A.
        • Valis M.
        • Aaen G.
        • et al.
        Delayed-release dimethyl fumarate safety and efficacy in pediatric patients with relapsing-remitting multiple sclerosis.
        Front Neurol. 2021; 11606418
        • Jacobson D.M.
        • Moster M.L.
        • Eggenberger E.R.
        • Galetta S.L.
        • Liu G.T.
        Isolated trochlear nerve palsy in patients with multiple sclerosis.
        Neurology. 1999; 53: 877-879